January 10-11, 2022
Hybrid conference
Pulsus Group welcomes you all on its new event, International conference on Biomarkers and Biobanking to be held on January 10-11, 2022 at Dubai, UAE. It features a keynote presentation, innovators, academicians from across cancer sites.
The basis of biomarkers 2022 is together prominent personalities and professionals from the sector of pharmacy, medicine, and research who share similar interests and ideologies in reference to particularly common diseases within the oncology department.
Biomarkers 2022 are intended to bring information about new advanced methodologies within the technologies utilized in biomarkers with the applications of Nanotech to curb nightmarish diseases like cancer.
The conference will offer a broad platform to share vital and up-to-date innovations within the field of biomarkers, immunology, biotechnology, pharmacology, neurology, microbiology. Biomarkers 2022 may be a two-day scientific event, business meeting, fair and trade with the Theme of “Unique Perspective and Leading Edge in Biomarkers and Biobanking”.
Biomarkers 2022 bring a chance to debate and study advances in biomarker research on access alongside unique and international experts, scientists and decision-makers from both academia and industry round the globe to exchange knowledge, innovations, and research and expertise within the field of cancer treatments.
Why to attend:
Biomarkers 2022 brings together experts from all aspects to satisfy and discuss the longer term of clinical research and therefore the importance of biomarkers in today’s world to survive with better health. This conference discusses technological developments, new discoveries, and up to date trends in biomarkers. there'll be lectures, interactions, discussions, keynote addresses, poster presentations, etc. This conference gives you an opportunity to find out more about biomarkers.
Benefits of attending:
A biomarker is a marker which will be precisely measured as a sign for conventional biological function, pathogenic paths, or drug response to therapeutic drug intervention. Biological markers are usually molecularly designed. Biological markers occur in various bodily functions, including diagnosis and forecast of disease, prediction and calculation of treatment response, and safety appraisal. These biomarkers are developed and approved to be used in drug development, and to support the approval of drug products.
Biobanking refers to the method by which samples of liquid body substance or tissue are collected for research use to enhance our understanding of health and disease
Related Societies: American association for Cancer research, American Society of Clinical Oncology, BASO-the association for Cancer surgery, Cent Pour Sang La Vie, French National Cancer Institute, American Neurological Association, North American Neuromodulation Society, European Academy of Neurology, American Board of Psychiatry and Neurology, ALS society of Canada
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
The biomarkers want to treat tumour are mentioned as tumour biomarkers. they're helpful in making precise diagnoses. Cancer biomarkers also identify and determine whether tumours are of primary or metastatic derivation. A biomarker for cancer is often a molecule produced by a tumour or a selected body response to the presence of tumour. Biomarkers of human prostate, breast, ovarian and lung cancers, also as those of heart condition, arthritis, asthma, and CF, are examined. Biological markers can determine the accuracy of the diagnosis, are often linked to other investigations to suspect the sort of cancer.
Related Societies: International society for oncology; French National Cancer Institute, Acute Cardiovascular Care Association; European Society of Cardiology, Cardiac Society of Australia; American Heart Association; The Genome consortium for active teaching; American Society for Human Genetics; American Society for Gene therapy; European Molecular Biology laboratory.
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Detection phases of clinical support and translated biomarkers are inclined to identify the effect of compound on organs or tissues before the clinical effect is exhibited. It is often classified into three general classes: biomarkers for disease, target biomarkers and Mechanism biomarkers. A biomarker for translation is predicated on whether it is often noticeable, quantifiable, and eventually it is often trained or verified.
Related Societies: Protein research foundation; Proteome Society; Australasian Proteomics Society; The Biomarkers consortium; International Society for Oncology and Biomarkers; Biomarkers profile corporation; World Molecular Imaging Society; European Society of Molecular Imaging; Biomarkers Society; Society of Nuclear Medicine and Molecular Imaging
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Cardiovascular disease (CVD) remains the foremost think about the world. The detection of traditional risk factors like age, hypertension, diabetes, and smoking enhanced the first prevention of CVD. Heart indicators are measured biomarkers to gauge heart function. they're often examined within the context of myocardial infarct, but other circumstances can cause a rise within the level of the gut’s marker. Cardiac biomarkers are elements that release into the blood when the guts are wounded or stretched. A heart marker is employed to spot and stratify proliferation of patients with pain and presumed acute coronary syndrome (ACS). These markers include enzymes, hormones, and proteins. Cardiac biomarkers have appeared as an important tool in cardiology over the past fifty years, namely for primary and secondary prevention, diagnosis, and treatment of acute myocardial infarct (AMI), and diagnosis and stratification of the danger of coronary failure.
Related Societies: International Pharmaceutical Federation; International Pharmaceutical Students Federation; Pharmaceutical Group of European Union (PGEU); Pharmaceutical Society of Australia; American Psychiatry Association; National Mental Health Organization
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Molecular biomarkers defined as biomarkers which will be revealed through basic and widely accepted proposals like genomics and proteomics, sideways from genomics and proteomics platforms, biomarker assessment techniques like metabolomics, lipidomic, glycaemic are most usually used as biomarker recognition techniques. Molecular biomarkers are categorized into pathological biomarkers, macromolecule biomarkers, Insilco biomarkers, glycoprotein biomarkers and bio-imaging markers buoyed their structure and functioning. These biomarkers are often tested for non-abnormally composed biological fluids, like blood or serum.
Related Societies: Alzheimer research forum; International Society for Oncology and Biomarkers; Associations of pet ownership with biomarkers of ageing; Animal Association Global Events in USA; Biomarker metabolites capturing the metabolite; Bioindicators and biomarkers in the Assessment; Independent and Synergistic Associations of Biomarkers
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Drug Finding with biomarkers is employed exclusively for diagnosis and monitoring of patients in clinical trials. Biological markers improve the success rates of drug advancement programs and thus hasten the supply of advanced therapies. Biomarker enhancement may be a multi-step and repetitive process starting with the invention of biomarkers in contagious diseases. during this session, an analytical authentication phase of biomarker development, pharmacogenomics, functional proteomics, biological analytical validation method, pharmacokinetic models are going to be created.
Related Societies: American association for Cancer research; American Society of Clinical Oncology; BASO-the association for Cancer surgery; Cent Pour Sang La Vie; French National Cancer Institute; American Neurological Association; North American Neuromodulation Society; European Academy of Neurology; American Board of Psychiatry and Neurology; ALS society of Canada
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarker
Bio markers are used as pinpointing tools for precisely identifying disease states, for identifying high-risk and predictable individuals, effectively treating patients with illnesses, and are targeted to specific biological sites. Advances in genomics, proteomics, metabolomics, and bioinformatics have made it possible to get several biomarkers
Related Societies: International society for oncology; French National Cancer Institute; Acute Cardiovascular Care Association; European Society of Cardiology; Cardiac Society of Australia; American Heart Association; The Genome consortium for active teaching; American Society for Human Genetics; American Society for Gene therapy; European Molecular Biology laboratory
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Blood biomarkers are engaged in MS (MS) studies, autoimmune dysfunction of the central systema nervosum. there's a big needn't met by biomarkers to assess prediction, response to treatment or potential complications in treatment. There are several constraints within the process of finding and validating an honest biomarker, like the pathophysiological complexity of MS and therefore the technical difficulties of a worldwide standard of methods for selection, processing, and maintaining biological trials.
Related Societies: Protein research foundation; Proteome Society; Australasian Proteomics Society; The Biomarkers consortium; International Society for Oncology and Biomarkers; Biomarkers profile corporation; World Molecular Imaging Society; European Society of Molecular Imaging; Biomarkers Society; Society of Nuclear Medicine and Molecular Imaging
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Biological markers are major tools in drug advancement and drug research. Biological markers are recognized for establishing the drug development process more efficient and becoming an important a part of pharmacology and drug research. Several biomarkers are expected to eventually be relocated to the clinical laboratory. Biological markers demonstrate drug-dose-response relationships between alterations in biomarker, onset of injury, and severity of injury according to the evolution of the injury.
Related Societies: International Pharmaceutical Federation; International Pharmaceutical Students Federation; Pharmaceutical Group of European Union (PGEU); Pharmaceutical Society of Australia; American Psychiatry Association; National Mental Health Organization
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Genomics-related biomarkers measure adjustments within the amount or nature of nucleic acids. DNA-founded biomarkers contain copy number modification, mutations, and epigenetic alteration. Biological markers supported RNA expression include quantification of mRNA, microRNA, and long non-coding RNA expression. The serum consists of several small size peptides, as a results of various cellular activities, called a serum proteome. Proteomics is widely utilized in the study of a good range of medical fields including drug development and biomarker discovery. By synchronizing with other advanced genomics and bioinformatics techniques, proteomics has the broad impact to identifying biomarkers and revolutionizing the drug development process.
Related Societies: Alzheimer research forum; International Society for Oncology and Biomarkers; Associations of pet ownership with biomarkers of ageing; Animal Association Global Events in USA; Biomarker metabolites capturing the metabolite; Bioindicators and biomarkers in the Assessment; Independent and Synergistic Associations of Biomarkers
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Neurology deals with the diagnosis and treatment of central and peripheral systema nervosum disease and is one among the standard restraints during which personalized medicine has become an essential a part of clinical trials. Various issues in neurology regarding individualized medicine and diagnostic, prognostic, and predictive biomarkers should be examined. The role of biomarkers and personalized medicine in neuro-oncology is becoming extremely critical. the state of data should be discussed in several areas of neurology.
Related Societies: American association for Cancer research; American Society of Clinical Oncology; BASO-the association for Cancer surgery; French National Cancer Institute; American Neurological Association; North American Neuromodulation Society; European Academy of Neurology; American Board of Psychiatry and Neurology; ALS society of Canada
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
The use of biomarkers and diagnostic appraisals continues to go forward with more uses and therefore the introduction of simpler sensitivity tests. These tests are powerful clinical care tools that deal with different therapeutic areas like oncology, immunology, cardiology, and endocrinology. Recent advances in biosensors to discover biomarkers in cancer therapy.
Related Societies: International society for oncology; French National Cancer Institute; Acute Cardiovascular Care Association; European Society of Cardiology; Cardiac Society of Australia; American Heart Association; The Genome consortium for active teaching; American Society for Human Genetics; American Society for Gene therapy; European Molecular Biology laboratory
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Biomarkers in health and disorders are worried about the promising findings during a paediatric autism spectrum disorder survey. The researchers were keen to use cerebral resonance imaging (MRI) to determine cortical and cerebrovascular development, in infants aged 6-12 months in danger of ASD with ASD affected children, who will have ASD up to 24 months. While this study requires further confirmation during a larger group of 15 out of 106 high-risk subjects who eventually developed ASD, it does mention the big and unmet medical need of biomarkers for neural and psychiatric disorders. Co-morbidity with other psychiatric disorders is additionally infrequent and promotes to dizzying heterogeneity in possible diagnoses. Clinical biomarkers can help go beyond these limitations.
Related Societies: Protein research foundation; Proteome Society; Australasian Proteomics Society; The Biomarkers consortium; International Society for Oncology and Biomarkers; Biomarkers profile corporation; World Molecular Imaging Society; European Society of Molecular Imaging; Biomarkers Society; Society of Nuclear Medicine and Molecular Imaging
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Bio markers play a critical role within the prediction and identification of varied cardiovascular and neurological diseases. Diseases that are lethal from age have possible treatment and straightforward diagnosis with advances in biomarkers using various diagnostic processes and imaging technologies. Cardiac biomarkers and neuro-biomarkers have modernized disease diagnosis and prediction. These biomarkers also are utilized in many other non-cancerous diseases. several the important ones are Alzheimer's disease, disorder, Huntington's chorea, condition, diabetes.
Related Societies: International Pharmaceutical Federation; International Pharmaceutical Students Federation; Pharmaceutical Group of European Union (PGEU); Pharmaceutical Society of Australia; American Psychiatry Association; National Mental Health Organization
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Bio-imaging markers are the category of biomarkers that allow earlier recognition of disease contrasted to molecular biomarkers, which optimizes the translational research in drug discovery and researchers under cancer images within the market. a few the image-based biomarkers are X-ray, computerized tomography (CT), positron emission tomography (PET), single emission computerized tomography (SPECT), and resonance imaging (MRI).
Related Societies: Alzheimer research forum; International Society for Oncology and Biomarkers; Associations of pet ownership with biomarkers of ageing; Animal Association Global Events in USA; Biomarker metabolites capturing the metabolite; Bioindicators and biomarkers in the Assessment; Independent and Synergistic Associations of Biomarkers
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Session 16: Digital Biomarkers
Digital biomarkers are frequently mentioned as a digital device diagnosis which will provide clinical information as substantial digital data. It can predict the physiological and behavioural findings of the patient's condition which establish what a healthy normal stage of disease and upcoming health outcomes. It is often called a self-diagnostic device which will be wearable, portable, transplantable, and digestible counting on diagnosis and condition.
Related Societies: American association for Cancer research; American Society of Clinical Oncology; BASO-the association for Cancer surgery; Cent Pour Sang La Vie; French National Cancer Institute; American Neurological Association; North American Neuromodulation Society; European Academy of Neurology; American Board of Psychiatry and Neurology; ALS society of Canada
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Biological or genetic tests are a group of tests that search for the molecular signs of health in order that doctors can best treat them. Biological markers, a basis for accurate oncology, are vital within the organization of oesophageal, breast and lung cancers. Testing practices are intensively assessed, influencing the level of diagnosis, and affecting pathologists, oncologists, and patients. Advances in biomarker testing are mostly within the fields of cancer that are divided into chromosomes, gene tests and biochemical tests. Micro-RNA biomarkers, number of other clinical biomarkers that have emerged within the latest study have begun the way for wider biomarker testing.
Related Societies: International society for oncology; French National Cancer Institute; Acute Cardiovascular Care Association; European Society of Cardiology; Cardiac Society of Australia; American Heart Association; The Genome consortium for active teaching; American Society for Human Genetics; American Society for Gene therapy; European Molecular Biology laboratory
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Biomarkers are wont to detect the occurrence of a disease or condition and to expose entities with a subtype of disease. Diagnostic biomarkers agree to the event of specialized cancer examination programs (cellular and molecular pathology). Therapeutic biomarkers affect an enormous sort of therapeutic medications for disorder, rarity, communicable disease, genetic disease.
Related Societies: Protein research foundation; Proteome Society; Australasian Proteomics Society; The Biomarkers consortium; International Society for Oncology and Biomarkers; Biomarkers profile corporation; World Molecular Imaging Society; European Society of Molecular Imaging; Biomarkers Society; Society of Nuclear Medicine and Molecular Imaging
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
Biobanks are compilations of human biological tissue specimens and correlated health data. Biobank research hopes to provide novel perceptions into the genetic factor of disease, eventually leading to a more customized approach to healthcare. And the need of biobanking is listed below. The primary role of biobanks is,
Related Societies: American association for Cancer research; American Society of Clinical Oncology; BASO-the association for Cancer surgery; Cent Pour Sang La Vie; French National Cancer Institute; American Neurological Association; North American Neuromodulation Society; European Academy of Neurology; American Board of Psychiatry and Neurology; ALS society of Canada
Keywords: Oncology; Genomics; Biomarkers; Cardiac biomarkers; Cancer biomarkers; Alzheimers biomarkers; Medicine Biomarkers; Neuro oncology; Molecular biomarkers
In 2019, the global biomarkers market size was valued at USD 46.3 billion and is anticipated to expand at a CAGR of 13.7% over the predicted period. High ubiquity of cancer is encouraging research initiatives, driving the growth of the market. Technological advancements and extensive research used for the development of biomarker-based clinical diagnostics are expected to be the key contributors for market. A rising number of Contract Research Organizations (CROs) is expected to further fuel the demand.
In 2020, the market size of global biobanks was estimated at USD 65.9 billion and is anticipated to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028. High investments for R&D of advanced therapies such as personalized medicine, regenerative medicine, and cancer genomic studies are driving the space. Moreover, the onset of COVID-19 has put bio banks at the cutting edge of pandemic control measures, resulting in the organic revenue growth of the market.
|
Report Attribute |
Details of Biomarkers |
Details of Biobanking |
|
Market size value in 2021 |
USD 73.3 billion |
USD 46.3 billion |
|
Growth rate |
USD 106.9 billion |
USD 78.1 billion |
|
Base year for estimation |
CAGR of 6.2% from 2021 to 2028 |
CAGR of 13.7% |
|
Forecast period |
2017 - 2019 |
2015 - 2018 |
|
Quantitative Units |
2021 - 2028 |
2020 - 2027 |
|
Market Representation |
Revenue in USD Million and CAGR from 2021 to 2028 |
Revenue in USD Million & CAGR from 2019 to 2027 |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; MEA |
North America, Europe, Asia Pacific, Latin America, MEA |
|
Country scope |
U.S.; Canada; Germany; U.K.; France; Spain; Italy; Japan; China; India; Australia; Singapore; Brazil; South Africa |
U.S., Canada, U.K., Germany, France, Spain, Italy, Japan, China, India, South Korea, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE |
Interested to join?? Worried about VISA??
To make your VISA process easier we do provide you with the following documents via Email with which you can avail your VISA from the Embassy
Important Note:
All the above documents will be issued only for the registered participants of the conference who had paid the conference fee.
To avail the above documents, you must provide us with the following
We have the following payment modes to make your registration easier
Need help for registration?
Kindly contact Program Manager, Elsie Fallon via
Email: biomarkers@pulsusseries.com
Whatsapp: +44 121 468 0849
Participants are honoured & Encouraged with Awards:
The International conference on Biomarkers & Biobanking encourages all attendees, including speakers, delegates, and young researchers, to compete.
Awards presented for the attendees:
The selection will be based on the following: